Distal emboli protection intervention in native coronary artery occlusion.
Karadag
Bilgehan
B
Division of Cardiology, University Hospital, Zurich, Switzerland. bilgehan.karadag@usz.ch
Eberli
Franz R
FR
Roffi
Marco
M
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D021721:Balloon Occlusion; D017023:Coronary Angiography; D003331:Coronary Vessels; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D013923:Thromboembolism / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D006493:Heparin; D001241:Aspirin; D000077284:Abciximab